Johnson & Johnson (JNJ) - Bull Of The Day
By Zacks Investment Research on March 27, 2009 | More Posts By Zacks Investment Research | Author's Website
Johnson & Johnson (JNJ) has an enormously diverse revenue stream consisting of market leading products in all three of its business segments. However, due to a number of products expected to experience declining sales, revenue will likely fall in 2009.
We expect EPS to remain flat from 2008, benefiting form improving margins and share buybacks. Then again, J&J s consistency, product diversity, financial stability and long-term growth potential make it a very attractive holding in this turbulent market.
We rate the stock a Buy based on the stock’s attractive valuation and strong company fundamentals. Our price target is $70.
If you like this article please...
Leave A Comment :
Recent Market Opinions:
3 Reasons Why ETNs Are Shrinking
AIG And Its Counterparties
Positioning For Year-End
Why Pimco’s Fleeing From Mortgage Debt Into Government Debt
US Bonds Are Blasting A Warning
Recent News:
Czech Consumer, Business Confidence Increase In November - less than 1 min ago
IMF To Expand Credit Arrangements To $600 Bln - 6 mins ago
*Italy November ISAE Consumer Confidence Index At 112.8, Consensus 111.5 - 7 mins ago
*Sweden Nov. Manufacturing Confidence Indicator Rises To Minus 10 From Minus 13 In October - 16 mins ago
Japanese Stock Market Ends Higher On Bargain Hunting, Dip-buying - 17 mins ago
Opinions From Our Contributors


